IMU

4.65%

4.5¢ imugene limited

Media Thread, page-8838

First 8838 Last

Share
Profile

Follow
Hittman

2,963 Posts.

262

10/05/23

14:55

Post #: 67702207
Share

Originally posted by Taureanbull ↑

As per my earlier post, regarding what would be the best path forward. Maybe Mobil Shah will demystify this aspect for us at the Bioshares Conference.

Many here are now expecting news about our CF33 programs. Maybe updated data from Checkvax or some solid data from Vaccinia. Both of these trials have the ability to bring a significant amount of attention from Big Pharma as well as the general investment community.

We could reasonably expect to see a lot of new information released from the Keynote Presentations at the Bioshares Summit. Bioshares and IMU don’t want old news that makes the room yawn.

So a few thoughts about just how big IMU could become if the MAST trial proves Vaccinia can obliterate solid tumours, in 5 or even 10 cancer types. Remember Yuman FONG tweeted “Any breast cancer is welcome”. So it’s not just 10 different specific cancers. It’s broad brush of cancer variants.

If we see Tumour Obliteration in 5 cancer types, IMU would have to be worth a minimum of US$50bn . The Seagen deal shows at $45bn shows how much cancer treatments are valued at.

A $50bn valuation is worth about $11 per share. A long way from our .11 cents current price. 100 bags just there. But we know BP will pay 5 X peaks sales for a successful drug. At this point IMU is effectively approaching the point where it should be valued the same as a drug close to finishing Ph3 trials. If the data stacks up for the trials which has patients lined up around the block , IMU will apply for breakthrough therapy. FDA will give a positive or negative response within 60 days. As an investor I would value this just like a successful post ph3 FDA approval. See Whatmighthavebens excellent post about Keytruda for further information on this process.

If the Solid tumor market is worth US$400BN then IMU could be worth as much as US$2Tn or $440 per share. Yes. I realise that’s an extremely big valuation. And there is still a way to go. But it does highlight the possibilities here if ll goes to plan. Is that 40,000% higher than current prices?.

I would doubt given the range of valuation there, we won’t need to wait for a signed deal to see investors piling in, if Vaccinia produces the results we are hoping for. We all know that curing cancer will be the medical world’s Moonshot. In the next few months we should have our answer.

Expand

I posted some time ago that I thought Imugene could well end up being a $50B company and still believe this to be the case. It's why I built up such a large holding over the last few months

IMU Price at posting: 12.3¢ Sentiment: Buy Disclosure: Held
22 Upvote

0 Great analysis

Reply

Top Stories

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What each US election outcome would mean for Australian companies & investors

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Making money: How many microcaps should be in an investor's portfolio?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

There are more pages in this discussion • 7,085 more messages in this thread...

First 8838 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.5¢		Change 0.002(4.65%)		Mkt cap ! $334.7M

Open	High	Low	Value	Volume
4.3¢	4.5¢	4.3¢	$732.0K	16.76M

Buyers (Bids)

No.	Vol.	Price($)
7	1799587	4.4¢

Sellers (Offers)

Price($)	Vol.	No.
4.5¢	1003772	13

View Market Depth

No.	Vol.	Price($)
6	1739587	0.044
20	1668819	0.043
25	1904223	0.042
21	2785272	0.041
50	5184850	0.040

Price($)	Vol.	No.
0.045	971457	11
0.046	2433385	9
0.047	1364948	8
0.048	1166612	6
0.049	341019	4

Last trade - 16.10pm 01/11/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-8838

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What each US election outcome would mean for Australian companies & investors

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Making money: How many microcaps should be in an investor's portfolio?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-8838

Top Stories

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What each US election outcome would mean for Australian companies & investors

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Making money: How many microcaps should be in an investor's portfolio?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News